Novem Group S.A.: Invitation to the Q3 2025/26 Results Presentation on 5 February 2026
January 29, 2026 — LUXEMBOURG - January 29, 2026 (NEWMEDIAWIRE) - Novem Group S. A.
NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
RSS Feed for NewMediaWireJanuary 29, 2026 — LUXEMBOURG - January 29, 2026 (NEWMEDIAWIRE) - Novem Group S. A.
January 29, 2026 — DALLAS - January 29, 2026 (NEWMEDIAWIRE) - Driven by an older, more diverse population and a significant increase in risk factors, at least 6 in 10 U. S.
January 29, 2026 — BEDMINSTER, NJ - January 29, 2026 (NEWMEDIAWIRE) - Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) (the "Company") announces its fourth quarter 2025 financial results. This earnings release should be read in conjunction with the Company’s Q4 2025 Investor Update, a copy of which is available on our website at www.
January 29, 2026 — LOS ANGELES, CA - January 29, 2026 (NEWMEDIAWIRE) - Forward Industries (NASDAQ: FWDI), a rapidly growing Solana treasury company, recently shared an update about the company’s total Solana (SOL) holdings (https://ibn. fm/TYP8i).
January 29, 2026 — Reinforces Synergistic Potential and Expands Opportunity Beyond Ovarian Cancer VANCOUVER, BC - January 29, 2026 (NEWMEDIAWIRE) - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) (“BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious disease, allergy, and other immune diseases based on its DPX™ antigen delivery and immune-educating technology platform, today announced positive findings from a Phase 2 clinical study evaluating maveropepimut-S (MVP-S) in combination with pembrolizumab and low-dose cyclophosphamide in patients with advanced or metastatic bladder cancer.
January 29, 2026 — Orders Included Hoodies and Headwear, Plus Bagging and Barcode Services to Support Direct-to-fan Fulfillment FORT WORTH, TX - January 29, 2026 (NEWMEDIAWIRE) - Just Right Products, Inc. (“Just Right Products”), a wholly owned subsidiary of ADM Endeavors, Inc.
January 29, 2026 — Key Highlights Nexus 20 sale to Critical Metals Corp, Tanbreez Project in Greenland’s CiTech to provide: Tetra voice /data radio package for safety and communications. Long range video surveillance.
January 29, 2026 — SAN DIEGO, CA - January 29, 2026 (NEWMEDIAWIRE) - Medical Marijuana, Inc. (OTC: MJNA) (the "Company") today announced a strategic alliance with AXIM Biotechnologies, Inc.
January 29, 2026 — ZINGER KEY POINTS Don’t miss REX Shares’ Feb. 5 Webinar on using options to generate income and capitalize on volatility in the markets.
January 29, 2026 — SAN DIEGO, CA - January 29, 2026 (NEWMEDIAWIRE) - AXIM Biotechnologies, Inc. (OTC: AXIM) (the "Company") today announced a strategic alliance with Medical Marijuana, Inc.
January 29, 2026 — VANCOUVER, BC - January 29, 2026 (NEWMEDIAWIRE) - Golden Goose Resources Ltd. (the “Company” or “Golden Goose”) is pleased to announce that it has entered into a Definitive Agreement with Valcheta Exploraciones S.
January 29, 2026 — VANCOUVER, BC - January 29, 2026 (NEWMEDIAWIRE) - Blue Lagoon Resources Inc. (CSE: BLLG; OTCQB: BLAGF; FSE: 7BL) continues to advance underground production at its 100%-owned Dome Mountain Gold & Silver Project as its milling partner, Nicola Mining Inc.
January 29, 2026 — HONG KONG - January 29, 2026 (NEWMEDIAWIRE) - Standard Chartered and the Hong Kong Trade Development Council (HKTDC) have jointly released the latest Standard Chartered Greater Bay Area Business Confidence Index (GBAI), which revealed that the business sentiment for most companies in the Greater Bay Area (GBA) remained steady amid persistent external uncertainties in Q4-2025. Following a rebound in the previous quarter, the GBAI indices showed a moderate quarter-on-quarter retreat in the fourth quarter of 2025.
January 29, 2026 — Research Highlights: Cerebral amyloid angiopathy, a condition caused by the buildup of amyloid (proteins) in brain blood vessels, was associated with increased risk of developing dementia within 5 years, in a study of nearly 2 million adults in the U. S.
January 29, 2026 — Research Highlights: Stroke survivors who felt they could not talk about their feelings or fears about their health with close friends or family reported feeling lonelier and had worse physical and mental recovery when assessed one year after the stroke. Difficulty sharing their feelings with family/friends was as important as the severity of the stroke for identifying patients who would experience greater disability and poorer physical function one year after the stroke.
January 29, 2026 — Research Highlights: A smartwatch used a machine learning algorithm to detect social interactions through sounds in the environment. This technology was able to measure how much social interaction occurred among stroke survivors in the hospital.
January 29, 2026 — Research Highlights: Adults who had a dissecting aneurysm in the neck artery wall (a cervical artery dissection or CeAD) did not have a higher risk of stroke compared to those with cervical artery dissection without a dissecting aneurysm in the first six months after diagnosis, according to data analysis from a global registry. The findings should offer reassurance and much-needed information about how best to diagnose and treat people with dissecting aneurysm and CeAD, researchers said.
January 29, 2026 — Research Highlights: A new risk prediction tool was able to accurately identify stroke survivors with the highest risk for developing dementia within a decade of having a stroke, according to a large study in Canada. Factors linked with a higher risk of developing dementia after a stroke included being older, having any disability before the stroke, having a higher level of disability after the stroke, having an intracerebral hemorrhage (compared to an ischemic stroke), having diabetes, experiencing cognitive symptoms during hospitalization or suffering from depression.
January 29, 2026 — Research Highlights: A study of over 200 adults followed for five years found that greater white matter damage in the brain was linked to decreased driving, fewer trips, repetitive routes and having more driving errors, especially in those who later developed dementia. In contrast, adults ages 65 and older who were taking blood pressure medicines, particularly ACE inhibitors, were less likely to show risky driving behaviors, even when brain damage was present (evidence of white matter damage caused by reduced blood flow to brain tissue).
January 29, 2026 — Research Highlights: Based on an analysis of a decade of hospital stroke registry data, people who had brain bleeds were more likely to die in the hospital if they were taking multiple antiplatelet medications, or medications stronger than aspirin, before the bleed. People who were taking only aspirin before the brain bleed had the same risk of death as those not taking any antiplatelet medications.